April 28, 2022
JelikaLite was awarded a National Science Foundation grant SBIR Phase 1: “EEG-guided intelligent transcranial photobiomodulation to reduce symptoms of autism”.   This new $256K grant will allow us to continue developing Cognilum, an intelligent non-invasive therapeutic personalized medical device, designed to be easily administered in the child’s home.  This data-device modality could be disruptive in the Autism treatment standard of care. 
Learn More

One thought on “JelikaLite was awarded a National Science Foundation grant SBIR Phase 1: “EEG-guided intelligent transcranial photobiomodulation to reduce symptoms of autism”.   This new $256K grant will allow us to continue developing Cognilum, an intelligent non-invasive therapeutic personalized medical device, designed to be easily administered in the child’s home.  This data-device modality could be disruptive in the Autism treatment standard of care. 

  1. I loved as much as you will receive carried out right here. The sketch is attractive, your authored subject matter stylish. nonetheless, you command get got an shakiness over that you wish be delivering the following. unwell unquestionably come further formerly again as exactly the same nearly very often inside case you shield this increase.

Leave a Reply

Your email address will not be published. Required fields are marked *